Scilex Holding (SCLX) FCF Margin (2022 - 2026)

Scilex Holding (SCLX) posted quarterly FCF Margin of 10.47% for Q1 2026, down 10967.0% year-over-year from N/an in Q1 2025, and up 102.9% on a QoQ basis from 360.97% in Q4 2025.

Scilex Holding (SCLX) FCF Margin (2022 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported FCF Margin for 5 consecutive years, with 10.47% the latest figure, recorded in Q1 2026.

  • In Q1 2026, FCF Margin fell 10967.0% year-over-year to 10.47%; the TTM figure through Mar 2026 stood at 3.81% (down 3529.0% YoY), while the FY2025 annual figure was 12.16%, down 2204.0% from the prior year.
  • FCF Margin came in at 10.47% for Q1 2026 at Scilex Holding, up from 360.97% in the prior quarter.
  • The five-year high for FCF Margin was 120.14% in Q1 2025, with the low at 360.97% in Q4 2025.
  • Average FCF Margin over 5 years is 22.8%, with a median of 14.12% recorded in 2024.
  • Across the five-year window, FCF Margin surged 15946 bps in 2024 and sank 37798 bps in 2025, its largest moves.
  • Year by year, FCF Margin stood at 6.08% in 2022, then plunged by 558 bps to 40.05% in 2023, then surged by 142 bps to 17.01% in 2024, then plunged by 2223 bps to 360.97% in 2025, then surged by 103 bps to 10.47% in 2026.
  • According to Business Quant data, FCF Margin over the past three periods registered 10.47%, 360.97%, and 77.53% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 15.19%
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 6.09%
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 23.76%
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 3.80%
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 17.97%
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 17.14%
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 34.87%
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 93.16%
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn 10.47%

Historic Data

Download Data
DateValue
Mar 31, 2026 10.47%
Dec 31, 2025 -360.97%
Sep 30, 2025 77.53%
Jun 30, 2025 71.68%
Mar 31, 2025 120.14%
Dec 31, 2024 17.01%
Sep 30, 2024 35.42%
Jun 30, 2024 14.12%
Mar 31, 2024 86.28%
Dec 31, 2023 -40.05%
Sep 30, 2023 58.11%
Jun 30, 2023 -107.08%
Mar 31, 2023 -73.18%
Dec 31, 2022 -6.08%
Sep 30, 2022 22.20%
Jun 30, 2022 -155.63%
Mar 31, 2022 -157.53%